Abstract
There have been a few epidemiological studies reporting VDR polymorphisms including Fok1, Bsm1, Apa1 and Taq1 with skin cancer incidence and, therefore, risk. The results, however, are controversial, often due to smaller sample size. Concerning most of the studies were performed on Caucasian population, we conducted this comprehensive analysis to better understand roles of the polymorphisms in skin cancer development among Caucasian population. The results showed that Fok1 polymorphism was associated with an overall significantly increased risk of skin cancer (Ff vs. FF: OR = 1.20, 95 % CI = 1.01–1.44; ff vs. FF: OR = 1.41, 95 % CI = 1.08–1.84; Ff + ff vs. FF: OR = 1.26, 95 % CI = 1.04–1.53). Besides, we found that Taq1 polymorphism could contribute to non-melanoma skin cancer susceptibility (Tt vs. TT: OR = 1.88, 95 % CI = 1.29–2.74; tt vs. TT: OR = 2.00, 95 % CI = 1.22–3.28; Tt + tt vs. TT: OR = 1.92, 95 % CI = 1.35–2.73). We also found that the Apa1 polymorphism is associated with skin cancer development (Aa vs. AA: OR = 1.27, 95 % CI = 1.05–1.53; Aa + aa vs. AA: OR = 1.23, 95 % CI = 1.04–1.47) and NMSC subgroup (Aa vs. AA: OR = 1.72, 95 % CI = 1.51–2.57; Aa + aa vs. AA: OR = 1.50, 95 % CI = 1.03–2.17). No significant association was observed between the Bsm1 polymorphism and skin cancer risk. The current meta-analysis shows that Fok1, Taq1 and Apa1 may be the susceptibility biomarker for skin cancer in Caucasians.
Similar content being viewed by others
References
Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14:1991–1997. doi:10.1158/1055-9965.EPI-04-0722
Barroso E, Fernandez LP, Milne RL et al (2008) Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case–control studies. BMC Cancer 23(8):385. doi:10.1186/1471-2407-8-385
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Faraco JM, Morrison NA, Baker A, Shin J, Frossard PM (1989) Apa1 dimorphism at the human vitamin D receptor gene locus. Nucl Acids Res 117:2150
Gapska P, Scott RJ, Serrano-Fernandez P, Mirecka A, Rassoud I, Górski B, Cybulski C, Huzarski T, Byrski T, Nagay L, Maleszka R, Sulikowski M, Lubinski J, Debniak T (2009) Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol 33(2):103–107. doi:10.1016/j.canep.2009.06.006
Gordon RM (2009) Skin cancer: more than skin deep. Adv Skin Wound Care 22:574–580
Gandini S, Raimondi S, Gnagnarella P, Doré JF, Maisonneuve P, Testori A (2009) Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 45:634–641
Han J, Colditz GA, Hunter DJ (2007) Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28(2):390–397 Epub 2006 Aug 31
Hutchinson PE, Osborne JE, Lear JT et al (2000) Vitamin D receptor polymorphism are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6(2):498–504
Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14:401–420
Köstner K, Denzer N, Koreng M, Reichrath S, Gräber S, Klein R, Tilgen W, Vogt T, Reichrath J (2012) Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population. Anticancer Res 32(1):327–333
Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29:3511–3536
Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826
Leiter U, Garbe C (2008) Epidemiology of melanoma and non-melanoma skin cancer-the role of sunlight. Adv Exp Med Biol 624:89–103
Lesiak A, Norval M, Wodz-Naskiewicz K, Pawliczak R, Rogowski-Tylman M, Sysa-Jedrzejowska A, Sobjanek M, Wlodarkiewicz A, Narbutt J (2011) An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes. Exp Dermatol 20(10):800–804. doi:10.1111/j.1600-0625
Li C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q (2008) Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case–control study. Int J Cancer. doi:10.1002/ijc.23357
Li C, Liu Z, Zhang Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q (2007) Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 127(2):276–280
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
Mellanby E (1976) Nutrition classics. The Lancet 1:407–412, 1919. An experimental investigation on rickets. Edward Mellanby.Nutr Rev. (11):338–340.
Mellanby E (2009) An experimental investigation on rickets. Nutr Rev 34:338–340
Mocellin S, Nitti D (2008) Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 113:2398–2407
Prinz-Langenohl RI, Fohr I, Pietrzik K (2001) Beneficial role for folate in the prevention of colorectal and breast cancer. Eur J Nutr 40(3):98–105
Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S, Karpavicius B, Marsden J, Gerry E, Bale L, Bertram C, Field H, Barth JH, Silva Idos S, Swerdlow A, Kanetsky PA, Barrett JH, Bishop DT, Bishop JA (2009) Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels and melanoma: UK case–control comparisons and a meta-analysis of published VDR data. Eur J Cancer 45:3271–3281
Santonocito C, Capizzi R, Concolino P et al (2007) Association between cutaneous melanoma, Breslow thickness and vitamin D receptor Bsm1 polymorphism. Br J Dermatol 156(2):277–282
Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94:1301–1311
Thorne J, Campbell MJ (2008) The vitamin D receptor in cancer. Proc Nutr Soc 67:115–127
Welsh J (2011) Vitamin D metabolism in mammary gland and breast cancer. Mol Cell Endocrinol 347:55–60
Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177(1–2):145–159
Zmuda JM, Cauley JA, Ferrell RE (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 22:203–217
Conflict of interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
X.-Z. Zhao and B.-H. Yang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhao, XZ., Yang, BH., Yu, GH. et al. Polymorphisms in the vitamin D receptor (VDR) genes and skin cancer risk in European population: a meta-analysis. Arch Dermatol Res 306, 545–553 (2014). https://doi.org/10.1007/s00403-014-1464-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-014-1464-8